Does semaglutide show up in routine blood work?

The question most people are really asking

When someone asks whether semaglutide shows up in blood work, they're usually weighing one of two things: either they want to know whether a routine test at their GP surgery will reveal they're taking it, or they're trying to understand why some of their blood results have shifted since starting treatment. Both are reasonable questions. The answer is different for each.

On the first point, standard NHS blood panels do not include semaglutide detection. A full blood count, metabolic panel, thyroid screen or HbA1c test measures what your body is producing or carrying, it isn't looking for the presence of specific medicines. Semaglutide would only appear in blood work if a clinician specifically ordered a serum immunoassay to detect it, which happens in pharmacokinetic research or monitoring programmes, not in a standard GP appointment. You can read a fuller explanation of how semaglutide interacts with testing on our semaglutide and blood test page.

On the second point, your results may well look different after a few months on treatment. That's a separate and genuinely useful thing to understand.

Which blood markers semaglutide can influence, and why

Semaglutide works partly by reducing appetite and slowing how quickly the stomach empties food into the small intestine. Weight loss that follows affects metabolic markers in ways that are broadly well-documented in clinical research. Several common routine markers may shift:

Liver enzymes (ALT, AST). Excess weight is associated with elevated liver enzymes due to fatty liver accumulation. As weight falls, these often improve. If your ALT was mildly elevated before treatment and normalises over the following months, that's a recognised effect of weight reduction rather than a sign of liver stress from the medicine itself.

Kidney markers (eGFR, creatinine). Reduced food intake and, occasionally, gastrointestinal side effects can affect hydration. A mild, transient change in creatinine during the early weeks is worth flagging to your prescriber, it's rarely serious but worth noting. For detailed context on how semaglutide relates to blood markers more broadly, the effects of semaglutide on blood work page covers this further.

Lipids (cholesterol, triglycerides). Clinical trials and real-world data consistently show improvements in lipid profiles over the course of treatment, linked to both the medicine's direct action and to weight loss.

HbA1c. In people with type 2 diabetes or prediabetes, blood-sugar control often improves noticeably. Even in people without diabetes, modest HbA1c reductions are commonly seen. The semaglutide overview covers the licensed indications in more detail, and if you want to understand how dosing is structured across the treatment journey, our semaglutide 7 page explains the specifics of that stage.

The NHS medicines page for semaglutide provides a clear patient-level reference for how the medicine works and what to expect.

Why weight loss itself accounts for much of what you see

One practical habit worth building: take a photo of your blood results before you start treatment and compare them at your next test six months in. It takes under a minute, and having that baseline makes it much easier to spot meaningful trends rather than reacting to a single out-of-range figure in isolation.

It's worth remembering that the body doesn't respond to a medicine and respond to weight loss as two separate events. They overlap. A drop in LDL cholesterol after four months on semaglutide might reflect the GLP-1 receptor agonist effect, the 8kg of weight lost, the dietary changes that came with reduced appetite, or some combination of all three. Trying to attribute every marker shift to the medicine alone isn't straightforward, and usually isn't necessary. What matters clinically is the direction of travel and your overall health picture.

If a result does shift in a direction that concerns you or your GP, that's a normal and good reason to speak to your prescriber. Our clinical team at nume reviews every repeat order before it's dispensed, questions about your blood work are part of that conversation, not an add-on. You can read about what our prescribers consider on the clinical team page.

For people exploring the cost side of treatment alongside the clinical questions, our Wegovy cost page lays out what private prescriptions typically include.

When to contact your GP or prescriber about a blood result

Most shifts in routine markers during semaglutide treatment are minor, expected and self-resolving. But some situations warrant a call rather than a wait.

Contact your GP or our prescribers promptly if routine bloods show a significant rise in liver enzymes (not a mild fluctuation, but a large unexplained jump), a sustained drop in kidney function, or a notable change in thyroid markers, particularly if you have a personal or family history of thyroid conditions, since medullary thyroid carcinoma is a contraindication for this class of medicine. The MHRA's Yellow Card scheme also allows patients and clinicians to report unexpected reactions they believe may be linked to a medicine.

Separately, if you experience persistent, severe stomach pain that seems to radiate toward your back, seek urgent medical attention regardless of what your blood results show, this warrants immediate assessment. You can find more about side effects and monitoring on our Wegovy page, and the FAQs cover many of the questions our patients raise in the first weeks of treatment.

If you're thinking about starting treatment and want a prescriber to review your clinical picture properly, you can check your eligibility with our team, it's free, and a real clinician reviews every consultation the same day.